470% price increases
World of DTC Marketing
MAY 26, 2021
According to AbbVie’s internal data, the company collected nearly $10 billion in Humira net revenue from Medicare Part D between 2010 and 2018. AbbVie has obtained or applied for over 250 patents on Humira to block competition from lower-priced biosimilars. Lack of Medicare Negotiation Costing Taxpayers Billions: U.S.
Let's personalize your content